Independent Research • No Ads • No Affiliate Links • CC BY 4.0

Kentucky GLP-1 Affordability: 17.5 Hours of Work for One Month of Medication

A Kentucky worker earning the median wage must work 2.2 full days to afford one month of GLP-1 medication, ranking #7 of 51 nationally.

2026 analysis using BLS wage data and current manufacturer pricing | Updated February 2026

#7
of 51 (50 states + DC) — 1 = least affordable
17.5
hours/month at
median wage
13.4%
of monthly
take-home pay
135.4%
of a year’s savings
spent on 12 months of Rx
Share this data:Download Stat Card (PNG)

Kentucky has the 6th-highest obesity rate in America — and a minimum-wage worker can’t earn enough in a full-time month to afford a single prescription.

For Press & Media: Quick Citations
Click [Copy] to copy citation with source link

According to the 2026 GLP-1 Affordability Index, Kentucky workers earning median wages must spend 13.4% of their monthly take-home pay — equivalent to 17.5 hours of work — to afford one month of GLP-1 weight loss medication at the best available self-pay price ($349/mo), ranking the state #7 of 51 nationally.

A year of GLP-1 medication at the current self-pay price ($4,188) consumes 135.4% of what the average Kentucky resident saves annually — meaning Kentucky workers must sacrifice 1.35 years of personal savings for 12 months of treatment.

At Kentucky's minimum wage of $7.25/hour, affording Wegovy at list price requires 186.1 hours of work per month — exceeding the 160 hours in a standard full-time work month, making the medication mathematically unaffordable through labor alone.

If you use this data or graphic in your reporting, a link to this page is appreciated.
vs. National Average: +2 hours worse
Neighboring States: Indiana #14, Ohio #24, West Virginia #3, Virginia #41
Kentucky Adult Obesity Rate: 38.7% (CDC 2024)
Kentucky Medicaid Covers GLP-1 for Obesity: No (KFF, Jan 2026)
⚠️ Kentucky is a “Double Bind” stateranking in the top 25 for obesity prevalence while ranking in the bottom half for GLP-1 affordability. The people who need this medication most are least able to afford it. Read the full Double Bind analysis →
Detailed Pricing Comparison
MetricSelf-Pay ($349/mo)Wegovy List ($1,349/mo)
Monthly Cost$349$1,349
Annual Cost$4,188$16,188
Hours at Median Wage ($19.98/hr)17.567.5
Hours at Minimum Wage ($7.25/hr)48.1186.1
% of Monthly Take-Home Pay13.4%51.9%
Working Days per Month2.28.4
Annual Cost as % of Savings135.4%523.2%
160-Hour Wall (Min Wage)NoYes
Source: BLS OEWS May 2024, DOL, Novo Nordisk
How Kentucky Compares to Neighboring States
StateMedian WageHours (Self-Pay)RankObesity Rate
Kentucky$19.9817.5#738.7%
Indiana$21.0716.6#1436.1%
Ohio$21.6216.1#2436.3%
West Virginia$18.4718.9#341.4%
Virginia$25.1513.9#4132.3%
Stat Card Preview
Kentucky GLP-1 Affordability: 17.5 hours of work per month
Copy embed code
<img src="https://weightlossproviderguide.com/research/images/glp1-statcard-kentucky.webp" alt="Kentucky GLP-1 Affordability: 17.5 hours of work per month" width="1200" height="630">
<p>Source: <a href="https://weightlossproviderguide.com/research/glp1-affordability-index/kentucky/">GLP-1 Affordability Index</a>, 2026</p>
Methodology: How we calculated these numbers

This analysis uses publicly available federal data to measure how affordable GLP-1 weight loss medications are for workers in each U.S. state.

WAGE DATA: Median hourly wages are from the Bureau of Labor Statistics Occupational Employment and Wage Statistics (OEWS) program, May 2024 release. We use the “All Occupations” (SOC 00-0000) median hourly wage for each state. Minimum wages reflect state rates effective January 1, 2026, from the U.S. Department of Labor Wage and Hour Division.

INCOME DATA: Median household income from the U.S. Census Bureau 2024 American Community Survey (ACS) 1-year estimates. Estimated annual savings calculated as median household income × 5.0%, assuming a 5% personal saving rate (illustrative estimate).

MEDICATION PRICING: Self-pay price of $349/month reflects Novo Nordisk self-pay cash pricing via NovoCare Pharmacy (terms apply; government beneficiaries excluded). Wegovy list price of $1,349/month reflects the wholesale acquisition cost (WAC). Both prices current as of February 2026.

NOTE: As of January 2026, an oral Wegovy pill is also available at $149–$299/mo via NovoCare Pharmacy. This analysis uses the Wegovy injectable self-pay price of $349/mo as the baseline.

HEALTH DATA: Adult obesity prevalence from the CDC Behavioral Risk Factor Surveillance System (BRFSS) 2024. Medicaid GLP-1 coverage status from KFF analysis as of January 2026.

CALCULATIONS:

  • Hours of work = Monthly drug cost ÷ hourly wage
  • % of take-home pay = Monthly drug cost ÷ (hourly wage × 173.33 hours/month × 0.75 tax adjustment) × 100
  • 160-Hour Wall = Flagged when hours at minimum wage for list price exceeds 160 (standard full-time month)
  • Double Bind = State has obesity rate ≥ 35% AND affordability rank in bottom half
  • Savings Wipeout = Annual drug cost ÷ estimated annual savings × 100

LIMITATIONS: Take-home pay estimate uses a flat 25% deduction for taxes/FICA, which varies by state and individual circumstances. Savings estimates are approximations. Actual out-of-pocket costs vary based on insurance, employer coverage, and eligibility for manufacturer programs.

Full dataset available for download: CSV Full methodology

Because Kentucky Medicaid does not cover GLP-1s for weight management, many residents are exploring regulated alternatives.

→ Read our 2026 guide: How Kentucky residents are accessing GLP-1 medications

Cite This Page

“GLP-1 Affordability Index: Kentucky.” Weight Loss Provider Guide, 2026.
https://weightlossproviderguide.com/research/glp1-affordability-index/kentucky/

Data sources: Bureau of Labor Statistics • U.S. Census Bureau • CDC • KFF • Novo Nordisk
Licensed under CC BY 4.0 • Last updated: February 2026
No ads. No affiliate links. Independent research.